A DirEct to PatieNt Study in Chronic Pain
Recruiting
- Conditions
- Chronic Pain
- Interventions
- Device: Commercially Approved Interventional Medical Device/Therapy for Chronic Pain
- Registration Number
- NCT05515341
- Lead Sponsor
- Boston Scientific Corporation
- Brief Summary
To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50000
Inclusion Criteria
- Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting
- Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening
- Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English
Key
Exclusion Criteria
- Requires a legal representative to sign the ICF ascertained from self-reporting
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Medical Device Therapy/Procedure for Chronic Pain Commercially Approved Interventional Medical Device/Therapy for Chronic Pain -
- Primary Outcome Measures
Name Time Method Change in pain post procedure up to 12 months Change in patient-reported pain on a scale of 0 - 10 where 0 is no pain and 10 is maximum pain
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Boston Scientific Neuromodulation
🇺🇸Valencia, California, United States